National Cancer Institute "Cancer Moonshot Biobank"

Recruiting in Palo Alto (17 mi)

+160 other locations

Overseen byHelen M Moore

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: National Cancer Institute (NCI)

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Eligibility Criteria

Inclusion Criteria

Colorectal cancer: Stage IV

Non-small cell or small cell lung cancer: stage III/IV

Prostate cancer: metastatic castration-resistant prostate cancer

See 7 more

Treatment Details

Interventions

Biospecimen Collection (Procedure)

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Ancillary-correlative (biospecimen collection, chart review)Experimental Treatment2 Interventions

Patients undergo collection of tissue and blood samples prior to initiation of treatment, during treatment, post treatment and at disease progression. Patients with hematological malignancies also undergo collection of bone marrow and cerebral spinal fluid at the same time points. Archival blood and tissue, as well as bone marrow of patients with hematological malignancies, is also collected, if available. Patient medical records are reviewed, and data is collected for at least 5 years.